Michael Schickler
General Counsel bei PURPLE BIOTECH LTD
Profil
Michael Schickler is the founder of CureTech Ltd.
(founded in 1995) and holds the title of Director.
He is currently the Chief Executive Officer at FameWave Ltd., Chairman at Mindset BioPharmaceuticals Ltd., and Head of Clinical Operations & Regulatory Affairs at Purple Biotech Ltd.
He has previously worked as a Director at MediWound Ltd.
and Accellta Ltd., Vice President of Development at W World Corp., and Principal at Hoffmann-La Roche, Inc. Dr. Schickler has an undergraduate and graduate degree from Tel-Aviv University and a doctorate from the Weizmann Institute of Science.
Aktive Positionen von Michael Schickler
Unternehmen | Position | Beginn |
---|---|---|
PURPLE BIOTECH LTD | General Counsel | 01.01.2020 |
Mindset BioPharmaceuticals Ltd.
Mindset BioPharmaceuticals Ltd. Medical/Nursing ServicesHealth Services Mindset BioPharmaceuticals Ltd. develops disease modifying therapies. It specializes in molecular neuropharmacology, behavioral science, clinical neurology, drug delivery, and biopharmaceutical development. The company was founded by Daniel G. Chain in February 1997 and is headquartered in Jerusalem, Israel. | Vorsitzender | - |
CureTech Ltd.
CureTech Ltd. BiotechnologyHealth Technology CureTech Ltd. operates as a biotechnology company. It develops novel and immune modulating products for the treatment and control of cancer. The company was founded by Michael Schickler in 1995 and is headquartered in Yavne, Israel. | Gründer | 27.06.1995 |
FameWave Ltd.
FameWave Ltd. Pharmaceuticals: MajorHealth Technology FameWave Ltd. is a biopharmaceutical company engaging in the development of medications for the treatment of cancer. Its product is CM-24. The company was founded on July 2, 2017 and is headquartered in Tel Aviv, Israel. | Vorstandsvorsitzender | 01.06.2018 |
Ehemalige bekannte Positionen von Michael Schickler
Unternehmen | Position | Ende |
---|---|---|
Accellta Ltd.
Accellta Ltd. BiotechnologyHealth Technology Accellta Ltd. offers solutions for stem cell culturing. Its portfolio include pluripotent stem cell culturing, human foreskin-derived feeder cells, growth media for feeder-free culturing of hPSC, stem cell expansion in suspension, stem cell culturing as single-cells in bioreactors, stem-cell controlled differentiation, and medium formulation. The company was founded in 2012 and is headquartered in Haifa, Israel. | Direktor/Vorstandsmitglied | - |
MEDIWOUND LTD. | Direktor/Vorstandsmitglied | - |
Hoffmann-La Roche, Inc.
Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Corporate Officer/Principal | - |
W WORL | Corporate Officer/Principal | - |
Ausbildung von Michael Schickler
Tel-Aviv University | Graduate Degree |
Weizmann Institute of Science | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 3 |
---|---|
W WORL | Health Technology |
MEDIWOUND LTD. | Health Technology |
PURPLE BIOTECH LTD | Health Technology |
Private Unternehmen | 5 |
---|---|
Hoffmann-La Roche, Inc.
Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Health Technology |
Mindset BioPharmaceuticals Ltd.
Mindset BioPharmaceuticals Ltd. Medical/Nursing ServicesHealth Services Mindset BioPharmaceuticals Ltd. develops disease modifying therapies. It specializes in molecular neuropharmacology, behavioral science, clinical neurology, drug delivery, and biopharmaceutical development. The company was founded by Daniel G. Chain in February 1997 and is headquartered in Jerusalem, Israel. | Health Services |
CureTech Ltd.
CureTech Ltd. BiotechnologyHealth Technology CureTech Ltd. operates as a biotechnology company. It develops novel and immune modulating products for the treatment and control of cancer. The company was founded by Michael Schickler in 1995 and is headquartered in Yavne, Israel. | Health Technology |
Accellta Ltd.
Accellta Ltd. BiotechnologyHealth Technology Accellta Ltd. offers solutions for stem cell culturing. Its portfolio include pluripotent stem cell culturing, human foreskin-derived feeder cells, growth media for feeder-free culturing of hPSC, stem cell expansion in suspension, stem cell culturing as single-cells in bioreactors, stem-cell controlled differentiation, and medium formulation. The company was founded in 2012 and is headquartered in Haifa, Israel. | Health Technology |
FameWave Ltd.
FameWave Ltd. Pharmaceuticals: MajorHealth Technology FameWave Ltd. is a biopharmaceutical company engaging in the development of medications for the treatment of cancer. Its product is CM-24. The company was founded on July 2, 2017 and is headquartered in Tel Aviv, Israel. | Health Technology |